CytRx Corporation Stock Nasdaq
Equities
US2328283013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | - | Capitalization | 644K 876K |
---|---|---|---|---|---|
Net income 2022 | -4M -5.45M | Net income 2023 | - 0 | EV / Sales 2022 | - |
Net cash position 2022 | 1.15M 1.56M | Net cash position 2023 | 2.04M 2.77M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.05
x | P/E ratio 2023 |
1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.44% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Snowdy
CEO | Chief Executive Officer | 55 | 22-01-09 |
John Caloz
DFI | Director of Finance/CFO | 72 | 07-09-30 |
Cristina Newman
SEC | Corporate Secretary | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer Simpson
CHM | Chairman | 55 | 21-07-28 |
Cary Claiborne
BRD | Director/Board Member | 64 | 22-07-26 |
Joel Caldwell
BRD | Director/Board Member | 69 | 17-07-11 |
1st Jan change | Capi. | |
---|---|---|
+33.51% | 49.46B | |
+1.78% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.66% | 26.61B | |
-22.09% | 18.64B | |
+7.89% | 13.16B | |
+29.51% | 12.55B | |
+23.56% | 12.1B |